Introduction: the objectives of the present study were to determine the mortality rate in patients over 60 years of age with COVID-19 and to identify risk factors. Methods: the present historical cohort study took place at the Kinshasa University Hospital (KUH), DRC. Older patients admitted from March 2020 to May 2021 and diagnosed COVID-19 positive at the laboratory were selected. The relationship between clinical and biological risk factors, treatment, and in-hospital mortality was modeled using Cox regression. Results: of two hundred and twenty-two patients at least 60 years old, 97 died, for a mortality rate of 43.69%. The median age was 70 years (64-74) with extremes of 60 to 88 years. Low oxygen saturation of < 90% (aHR 1.69; 95% CI [1.03-2.77]; p=0.038) was an independent predictor of mortality. The risk of death was reduced with corticosteroid use (aHR 0.54; 95% CI [0.40-0.75]; p=0.01) and anticoagulant treatment (aHR 0.53; 95% CI [0.38-0.73]; p=0.01). Conclusion: mortality was high in seniors during COVID-19 and low oxygen saturation on admission was a risk factor for mortality. Corticosteroid therapy and anticoagulation were protective factors. These should be considered in management to reduce mortality. Copyright: Ben Bepouka et al.
Introduction: the objectives of the present study were to determine the mortality rate in patients over 60 years of age with COVID-19 and to identify risk factors. Methods: the present historical cohort study took place at the Kinshasa University Hospital (KUH), DRC. Older patients admitted from March 2020 to May 2021 and diagnosed COVID-19 positive at the laboratory were selected. The relationship between clinical and biological risk factors, treatment, and in-hospital mortality was modeled using Cox regression. Results: of two hundred and twenty-two patients at least 60 years old, 97 died, for a mortality rate of 43.69%. The median age was 70 years (64-74) with extremes of 60 to 88 years. Low oxygen saturation of < 90% (aHR 1.69; 95% CI [1.03-2.77]; p=0.038) was an independent predictor of mortality. The risk of death was reduced with corticosteroid use (aHR 0.54; 95% CI [0.40-0.75]; p=0.01) and anticoagulant treatment (aHR 0.53; 95% CI [0.38-0.73]; p=0.01). Conclusion: mortality was high in seniors during COVID-19 and low oxygen saturation on admission was a risk factor for mortality. Corticosteroid therapy and anticoagulation were protective factors. These should be considered in management to reduce mortality. Copyright: Ben Bepouka et al.
Authors: Junior Rika Matangila; Ritha Kibambe Nyembu; Gloire Mosala Telo; Christian Djuba Ngoy; Taty Msueun Sakobo; Joel Mbembo Massolo; Blandine Mbo Muyembe; Richard Kapela Mvwala; Cedric Kabemba Ilunga; Emmanuel Bakilo Limbole; Jeff Mukengeshay Ntalaja; Roger Minga Kongo Journal: PLoS One Date: 2020-12-18 Impact factor: 3.240
Authors: Laura Skrip; Karim Derra; Mikaila Kaboré; Navideh Noori; Adama Gansané; Innocent Valéa; Halidou Tinto; Bicaba W Brice; Mollie Van Gordon; Brittany Hagedorn; Hervé Hien; Benjamin M Althouse; Edward A Wenger; André Lin Ouédraogo Journal: Int J Infect Dis Date: 2020-09-26 Impact factor: 3.623
Authors: Maria Mazzitelli; Eugenio Arrighi; Francesca Serapide; Maria Chiara Pelle; Bruno Tassone; Rosaria Lionello; Giuseppina Marrazzo; Domenico Laganà; Francesco Saverio Costanzo; Giovanni Matera; Enrico Maria Trecarichi; Carlo Torti Journal: J Med Virol Date: 2020-09-30 Impact factor: 20.693
Authors: Simon P Jochems; Fernando Marcon; Beatriz F Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Stephen B Gordon; Jamie Rylance; Helder I Nakaya; Daniela M Ferreira Journal: Nat Immunol Date: 2018-10-29 Impact factor: 25.606